Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A27543 | 18095746 | Drug Saf | Orlistat-associated adverse effects and drug interactions: a critical review. | 2008 | Details |
A27544 | 18094066 | Am J Physiol Regul Integr Comp Physiol | Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. | 2007 | Details |
A27545 | 18090161 | J Clin Gastroenterol | Liver enzymes and histology in obese patients with obstructive sleep apnea. | 2008 | Details |
A27546 | 18088037 | Srp Arh Celok Lek | [Ultrasonography findings of liver in textile workers for diagnosing nonalcoholic fatty liver disease]. | 2008 | Details |
A27547 | 18087267 | Int J Obes (Lond) | Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. | 2007 | Details |
A27548 | 18086620 | Hepatobiliary Pancreat Dis Int | Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. | 2007 | Details |
A27549 | 18086506 | J Hepatol | Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. | 2007 | Details |
A27550 | 18083083 | Dig Liver Dis | Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). | 2007 | Details |
A27551 | 18081738 | Aliment Pharmacol Ther | Adipokines and cytokines in non-alcoholic fatty liver disease. | 2007 | Details |
A27552 | 18081233 | World J Gastroenterol | Prevalence of fatty liver disease and its risk factors in the population of South China. | 2007 | Details |
A27553 | 18081207 | Mol Nutr Food Res | Phenolic compounds: evidence for inhibitory effects against obesity and their underlying molecular signaling mechanisms. | 2008 | Details |
A27554 | 18075282 | J Endocrinol Invest | Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis. | 2007 | Details |
A27555 | 18074849 | Zhong Yao Cai | [Variances of leptin mRNA in the adipose tissue of NAFLD rats intervened with the extracts of Polygonum cuspidatum compound]. | 2007 | Details |
A27556 | 18074737 | Acta Gastroenterol Belg | Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease. | 2008 | Details |
A27557 | 18074733 | Acta Gastroenterol Belg | Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention. | 2008 | Details |
A27558 | 18073067 | Zhonghua Gan Zang Bing Za Zhi | [The relationship between the opening of mitochondrial permeability transition pores of cultured hepatocytes with their apoptoses in a non-alcoholic fatty liver disease model]. | 2007 | Details |
A27559 | 18072723 | Mol Pharm | Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets. | 2007 | Details |
A27560 | 18066656 | Inflammation | The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. | 2007 | Details |
A27561 | 18062158 | Praxis (Bern 1994) | [Non-alcoholic steatohepatitis--a new epidemic]. | 2007 | Details |
A27562 | 18061659 | Mol Aspects Med | Mitochondrial involvement in non-alcoholic steatohepatitis. | 2007 | Details |
A27563 | 18058083 | Diabetologia | Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. | 2007 | Details |
A27564 | 18057936 | Pathologe | [Hepatocellular carcinoma in the non-cirrhotic liver]. | 2008 | Details |
A27565 | 18056890 | Diabetes Care | Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. | 2007 | Details |
A27566 | 18054554 | Gastroenterology | Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. | 2007 | Details |
A27567 | 18051925 | J Pediatr Endocrinol Metab | Non-alcoholic fatty-liver disease in pediatric populations. | 2007 | Details |
A27568 | 18047583 | Hepatol Res | Sex- or gender-specific medicine in hepatology. | 2007 | Details |
A27569 | 18042105 | Am J Gastroenterol | Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). | 2007 | Details |
A27570 | 18038452 | Hepatology | Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers. | 2008 | Details |
A27571 | 18035683 | Verh Dtsch Ges Pathol | [Alcoholic and non-alcoholic steatohepatitis]. | 2005 | Details |
A27572 | 18031368 | J Gastroenterol Hepatol | Significant correlations between severe fatty liver and risk factors for metabolic syndrome. | 2007 | Details |
A27573 | 18030620 | Dig Dis Sci | Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis. | 2007 | Details |
A27574 | 18025069 | Gut | Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. | 2007 | Details |
A27575 | 18022391 | FEBS Lett | Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. | 2007 | Details |
A27576 | 18019712 | Hepatogastroenterology | Body mass index in Japanese patients with autoimmune liver disease: overweight patients with primary biliary cirrhosis tend to be asymptomatic. | 2007 | Details |
A27577 | 17935056 | Diab Vasc Dis Res | The role of fenofibrate in clinical practice. | 2007 | Details |
A27578 | 18007556 | Ann Hepatol | Changes in histological criteria lead to different prevalences of nonalcoholic steatohepatitis in severe obesity. | 2008 | Details |
A27579 | 18007554 | Ann Hepatol | Dipeptidyl peptidase IV (DDP IV) in NASH patients. | 2008 | Details |
A27580 | 18007551 | Ann Hepatol | Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. | 2008 | Details |
A27581 | 18004085 | Am J Med Sci | The effects of weight loss on normal transaminase levels in obese patients. | 2007 | Details |
A27582 | 18000721 | Obes Surg | Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. | 2007 | Details |
A27583 | 17999673 | Liver Int | Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people. | 2007 | Details |
A27584 | 17990373 | AIDS Read | Nonalcoholic fatty liver disease: an increasingly common cause of liver disease among HIV-infected persons? | 2007 | Details |
A27585 | 17986744 | Indian J Gastroenterol | Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease. | 2008 | Details |
A27586 | 17986629 | Am J Physiol Endocrinol Metab | Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet. | 2007 | Details |
A27587 | 17983937 | Endocrinol Metab Clin North Am | Use of insulin sensitizers in NASH. | 2007 | Details |
A27588 | 17983472 | BMC Gastroenterol | Prevalence and factors associated with the presence of non alcoholic fatty liver disease in an apparently healthy adult population in primary care units. | 2007 | Details |
A27589 | 17976158 | Liver Int | Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis. | 2007 | Details |
A27590 | 17975129 | Am J Physiol Gastrointest Liver Physiol | Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver. | 2007 | Details |
A27591 | 17970546 | Nutr Hosp | [Morbid obesity, non-alcoholic fatty liver disease, metabolic syndrome and bariatric surgery]. | 2007 | Details |
A27592 | 17965629 | Gastroenterol Clin Biol | [Management of HCV-HIV patients]. | 2008 | Details |
A27593 | 17964913 | Med Clin North Am | Nonalcoholic fatty liver disease as a complication of insulin resistance. | 2007 | Details |
A27594 | 17958019 | Rev Med Brux | [How to interpret a hyperferritinemia?]. | 2007 | Details |
A27595 | 17953248 | Obes Surg | Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease. | 2007 | Details |
A27596 | 17951208 | Am J Clin Pathol | Pathology of nonalcoholic fatty liver disease. | 2007 | Details |
A27597 | 17950097 | Metabolism | Regulation of adiponectin receptor expression in human liver and a hepatocyte cell line. | 2007 | Details |
A27598 | 17941908 | Clin Endocrinol (Oxf) | Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease. | 2007 | Details |
A27599 | 17939039 | Dig Dis Sci | Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease. | 2007 | Details |
A27600 | 17937811 | BMC Gastroenterol | Meta-analyses of FibroTest diagnostic value in chronic liver disease. | 2007 | Details |
A27601 | 17934820 | Dig Dis Sci | Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease. | 2007 | Details |
A27602 | 17932230 | Am J Physiol Gastrointest Liver Physiol | The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis. | 2007 | Details |
A27603 | 17928738 | J Pharmacol Sci | Life style-related diseases of the digestive system: gene expression in nonalcoholic steatohepatitis patients and treatment strategies. | 2007 | Details |
A27604 | 17919226 | Liver Int | Treating nonalcoholic fatty liver disease. | 2007 | Details |
A27605 | 17918488 | Rev Med Suisse | [Liver disease in obese patients]. | 2007 | Details |
A27606 | 17917083 | Med Oncol | A case-control study of non-alcoholic fatty liver disease in breast cancer. | 2007 | Details |
A27607 | 17916170 | Intern Med J | The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations. | 2007 | Details |
A27608 | 17914984 | J Gastroenterol Hepatol | Preventive role of genistein in an experimental non-alcoholic steatohepatitis model. | 2007 | Details |
A27610 | 17910660 | Pediatr Transplant | Recurrence of non-alcoholic steatohepatitis after liver transplantation in a 13-yr-old boy. | 2007 | Details |
A27611 | 17906183 | J Am Coll Nutr | Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men. | 2007 | Details |
A27612 | 17904683 | Diabetes Res Clin Pract | Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2007 | Details |
A27613 | 17903399 | J Coll Physicians Surg Pak | A clinical and biochemical profile of biopsy-proven non-alcoholic Fatty liver disease subjects. | 2007 | Details |
A27616 | 17903363 | Zhonghua Gan Zang Bing Za Zhi | [The prevalence of non-alcoholic fatty liver disease and its related risk factors in 1180 school children in Shanghai]. | 2007 | Details |
A27618 | 24573937 | Front Med China | Pathological study of 130 cases of nonalcoholic fatty liver disease based on NASH-CRN system. | 2007 | Details |
A27619 | 17902213 | Int J Pediatr Obes | Estimated burden of paediatric obesity and co-morbidities in Europe. Part 2. Numbers of children with indicators of obesity-related disease. | 2006 | Details |
A27620 | 17900521 | Biochim Biophys Acta | Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin. | 2007 | Details |
A27621 | 17900249 | Liver Int | Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period. | 2007 | Details |
A27622 | 17896969 | Curr HIV Res | Steatohepatitis in HIV-infected subjects: pathogenesis, clinical impact and implications in clinical management. | 2007 | Details |
A27623 | 17896181 | Eur J Epidemiol | Prevalence of non-alcoholic fatty liver and characteristics in overweight adolescents in the general population. | 2007 | Details |
A27624 | 17894848 | Am J Gastroenterol | The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. | 2007 | Details |
A27625 | 17892532 | J Thromb Haemost | Hypercoagulation and thrombophilia in liver disease. | 2007 | Details |
A27626 | 17890486 | Obesity (Silver Spring) | Hepatic steatosis and increased adiposity in mice consuming rapidly vs. slowly absorbed carbohydrate. | 2007 | Details |
A27627 | 17880357 | Br J Clin Pharmacol | Ischaemic complications of Glypressin in liver disease: a case series. | 2007 | Details |
A27628 | 17879403 | World J Gastroenterol | Liver biopsy in a district general hospital: changes over two decades. | 2007 | Details |
A27629 | 17877759 | Clin Endocrinol (Oxf) | Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases. | 2007 | Details |
A27630 | 17877502 | Hepatol Res | Epidemiology of hepatocellular carcinoma in USA. | 2007 | Details |
A27631 | 17875176 | J Intern Med | Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. | 2007 | Details |
A27632 | 17874726 | Vojnosanit Pregl | [Non-alcoholic fatty liver disease in obese persons with diabetes]. | 2007 | Details |
A27633 | 17872748 | Can Fam Physician | Managing nonalcoholic fatty liver disease: recommendations for family physicians. | 2007 | Details |
A27634 | 17868334 | J Gastroenterol Hepatol | Interstrain differences in susceptibility to non-alcoholic steatohepatitis. | 2007 | Details |
A27635 | 17868330 | J Gastroenterol Hepatol | Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation. | 2007 | Details |
A27636 | 17867371 | Nutr Rev | Nonalcoholic fatty liver disease: pathogenesis, identification, progression, and management. | 2007 | Details |
A27637 | 17850914 | J Hepatol | Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. | 2007 | Details |
A27638 | 17846888 | Dig Dis Sci | Fibrogenesis in fatty liver associated with obesity and diabetes mellitus type 2. | 2007 | Details |
A27639 | 17845148 | Expert Opin Ther Targets | Present and future therapeutic strategies in non-alcoholic fatty liver disease. | 2007 | Details |
A27640 | 17826687 | Drug Discov Today | Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). | 2007 | Details |
A27641 | 17823431 | Am J Clin Nutr | Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake. | 2007 | Details |
A27642 | 17786144 | Ann Hepatol | Angiogenesis in chronic liver disease. | 2007 | Details |
A27643 | 17786142 | Ann Hepatol | Prevalence of non-alcoholic fatty liver disease: population based study. | 2007 | Details |
A27644 | 17785073 | Zhonghua Yi Xue Za Zhi | [Effects of calorie restriction on SIRT1 expression in liver of nonalcoholic fatty liver disease: experiment with rats]. | 2007 | Details |
A27645 | 17767466 | Aliment Pharmacol Ther | Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability. | 2007 | Details |
A27646 | 17767465 | Aliment Pharmacol Ther | Health-related quality of life in patients with non-alcoholic fatty liver disease. | 2007 | Details |